GlassScriptPhysician profile
Alejandro Maldonado
NPI 1699394726
$963.56
in general payments reported to CMS, 2019-2025
10 companies · $964 in 2025
The $964 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $250.32 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $201.16 | 2025 | Lokelma, Farxiga |
| Boston Scientific Corporation | $125.39 | 2025 | Emblem Mri S-Icd |
| E.R. Squibb & Sons, L.L.C. | $117.40 | 2025 | Camzyos |
| Kestra Medical Technology Services, INC. | $84.83 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $76.22 | 2025 | Cleviprex, Kengreal |
| Medtronic, INC. | $46.09 | 2025 | Cobalt Dr Mri Surescan |
| Pfizer INC. | $24.13 | 2025 | |
| Penumbra, INC. | $22.14 | 2025 | Indigo System |
| Idorsia Pharmaceuticals US INC | $15.88 | 2025 | Tryvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Maldonado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.